Correlation Between Tscan Therapeutics and Chimerix
Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and Chimerix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and Chimerix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tscan Therapeutics and Chimerix, you can compare the effects of market volatilities on Tscan Therapeutics and Chimerix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of Chimerix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and Chimerix.
Diversification Opportunities for Tscan Therapeutics and Chimerix
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Tscan and Chimerix is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and Chimerix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chimerix and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with Chimerix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chimerix has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and Chimerix go up and down completely randomly.
Pair Corralation between Tscan Therapeutics and Chimerix
Given the investment horizon of 90 days Tscan Therapeutics is expected to generate 1.5 times more return on investment than Chimerix. However, Tscan Therapeutics is 1.5 times more volatile than Chimerix. It trades about 0.07 of its potential returns per unit of risk. Chimerix is currently generating about -0.12 per unit of risk. If you would invest 454.00 in Tscan Therapeutics on September 1, 2024 and sell it today you would earn a total of 23.00 from holding Tscan Therapeutics or generate 5.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tscan Therapeutics vs. Chimerix
Performance |
| Timeline |
| Tscan Therapeutics |
| Chimerix |
Tscan Therapeutics and Chimerix Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tscan Therapeutics and Chimerix
The main advantage of trading using opposite Tscan Therapeutics and Chimerix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, Chimerix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chimerix will offset losses from the drop in Chimerix's long position.| Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
| Chimerix vs. Tff Pharmaceuticals | Chimerix vs. Eliem Therapeutics | Chimerix vs. Inhibrx | Chimerix vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |